It is not known whether it is safe to consume alcohol with Deferataj 250mg Tablet DT. Please consult your doctor.
Deferataj 250mg Tablet DT may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Deferataj 250mg Tablet DT is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Deferataj 250mg Tablet DT may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Deferataj 250mg Tablet DT is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Deferataj 250mg Tablet DT should be used with caution in patients with liver disease. Dose adjustment of Deferataj 250mg Tablet DT may be needed. Please consult your doctor.<BR>Limited information is available on the use of Deferataj 250mg Tablet DT in these patients.
Deferataj 250mg Tablet DT traps and removes excess iron which is then excreted mainly in the stools. This reduces the risk of organ damage.
Deferataj works by binding to excess iron in the blood and removing it from the body through stool.
Deferataj is used for removing excess iron from the body due to repeated blood transfusions in patients with beta thalassemia major (a blood disorder)
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA